Hugendubel.info - Die B2B Online-Buchhandlung 

Merkliste
Die Merkliste ist leer.
Bitte warten - die Druckansicht der Seite wird vorbereitet.
Der Druckdialog öffnet sich, sobald die Seite vollständig geladen wurde.
Sollte die Druckvorschau unvollständig sein, bitte schliessen und "Erneut drucken" wählen.

Neuroblastoma

Previously published in hardcover
BuchKartoniert, Paperback
262 Seiten
Englisch
Springer Netherlandserschienen am23.08.2016Softcover reprint of the original 1st ed. 2012
Introduction of new technologies and their applications to neuroblastoma diagnosis, treatment, and therapy assessment are explained. Targets for therapeutic intervention in neuroblastoma are identified, including targeting multidrug resistance in this cancer.mehr
Verfügbare Formate
BuchGebunden
EUR160,49
BuchKartoniert, Paperback
EUR160,49

Produkt

KlappentextIntroduction of new technologies and their applications to neuroblastoma diagnosis, treatment, and therapy assessment are explained. Targets for therapeutic intervention in neuroblastoma are identified, including targeting multidrug resistance in this cancer.
ZusammenfassungAs well as detailing the applications of new technology to neuroblastoma diagnosis, treatment, and therapy assessment, this volume covers subjects such as the role of molecular genetics in the diagnosis and treatment of patients with neuroblastoma.
Details
ISBN/GTIN978-94-017-7909-8
ProduktartBuch
EinbandartKartoniert, Paperback
Erscheinungsjahr2016
Erscheinungsdatum23.08.2016
AuflageSoftcover reprint of the original 1st ed. 2012
ReihePediatric Cancer
Seiten262 Seiten
SpracheEnglisch
Gewicht634 g
IllustrationenXVIII, 262 p.
Artikel-Nr.43751131
Rubriken
GenreMedizin

Inhalt/Kritik

Inhaltsverzeichnis
Preface.-1. Introduction. I Diagnosis and biomarkers.-2. Pediatric cns neuroblastoma: magnetic resonance imaging and spectroscopy.-3. Pediatric neuroblastoma-associated opsoclonus-myoclonus-ataxia syndrome: early diagnosis.-4. Neuroblastoma mouse model.-5. Orbital metastasis in neuroblastoma patients.-6. Pediatric neuroblastoma: molecular detection of minimal residual disease.-7. A comprehensive tissue microarray-based fish screen of alk gene in neuroblastomas. II Therapy.-8. Neuroblastoma: triptolide therapy.-9. Neuroblastoma: ornithine decarboxylase and polyamines are novel targets for therapeutic intervention.-10. Neuroblastoma: antibody-based immunotherapy.-11. Targeting multidrug resistance in neuroblastoma.-12. Neuroblastoma: perspectives for the use of il-21 in immunotherapy.-13. Neuroblastoma: role of hypoxia and hypoxia inducible factors in tumor progression.-14. Neuroblastoma: role of gata transcription factors.-15. Neuroblastoma: role of mycn/bmil pathway in neuroblastoma.-16. Neuroblastoma: role of clusterin as a tumor suppressor gene.-17. Refractory neuroblastoma cells: statins target atp binding cassette-transporters.-18. Neuroblastoma: dosimetry for mibg therapies.-19. Advanced neuroblastoma: role of alk mutations.-20. Pediatric neuroblastoma: treatment with oral irinotecan and temozolomide. III Prognosis.-21. Genomic profiling of neuroblastoma tumors- prognostic impact of genomic aberrations.-22. Neuroblastoma patients: plasma growth factor mildkine as a prognostic growth factor.-23. Pediatric neuroblastoma: role of tgfbi (keratoepithelin).-24. Role of bone marrow infiltration detected by sensitive methods in patients with localized neuroblastoma. Indexmehr